Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PAROXETINE HYDROCHLORIDE
- Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer
- Concentration-QT Study of Paroxetine in Healthy Adults
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
- Influence of Oxycodone on Individuals Taking an SSRI
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
- Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation
- Measurement-Based Care Vs. Standard Care for Major Depressive Disorder
- Cariprazine Versus Placebo for Social Anxiety Disorder
- Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
- Postpartum MDMA Co-occurring PTSD and OUD
- EEG Results of Deep TMS in Patients With OCD
- Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants
- A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
- The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients
- Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
- Sequenced Treatment Effectiveness for Posttraumatic Stress
- Treatment of Tinnitus With Migraine Medications
- Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants
- Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
- Endobiotics for Phenotyping of Human Cytochrome P450 Enzymes
- Vortioxetine for the Treatment of Hoarding Disorder
- Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment
- Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
- Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
- Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
- Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders
- Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
- Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal Treatments
- Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6
- Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
- Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers
- Stellate Ganglion Blockade in Post-Menopausal Women
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
- Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
- A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
- Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
- Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
- Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome
- Pharmacovigilance in Gerontopsychiatric Patients
- Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
- Intervention Study for Individuals With Compulsive Sexual Behavior
- The Gut Microbiota in Obsessive-Compulsive Disorder
- Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder
- Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
- Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
- The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial
- A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Neurobiology of Eating Disorders Treatments
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
- Interpersonal Psychotherapy for Treatment Resistant Depression
- Interaction Between Paroxetine and Telaprevir
- Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women
- Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study
- Ketamine in the Treatment of Suicidal Depression
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
- Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
- Vilazodone for Treatment of Geriatric Depression
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement
- Lithium Versus Paroxetine in Major Depression
- Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
- Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
- Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
- Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
- Special Drug Use Investigation for PAXIL Tablet (Long-term)
- Drug Use Investigation for PAXIL Tablet
- Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
- Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
- Paxil CR Bioequivalence Study Brazil - Fed Administration
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine
- Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects
- Paxil CR Bioequivalence Study Brazil
- Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
- Lexapro for Major Depression in Patients With Epilepsy
- Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
- A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers
- An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
- Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack
- 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
- Amitriptyline and Paroxetine Treatment of Major Depression
- Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
- Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects
- Trial of Aripiprazole in Trichotillomania
- Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
- Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Lamotrigine Augmentation in Resistant Depression
- Interaction Study of Timolol Eye Drops and Paroxetine Capsules
- Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
- Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
- Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions
- BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
- Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
- Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine
- Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine
- Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
- A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
- Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
- Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study
- Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder
- PAXIL CR Bioequivalence Study
- Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
- Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
- Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
- Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)
- A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
- Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)
- A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
- Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)
- Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
- Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
- Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
- Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
- Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
- Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
- Early Intervention for Post Traumatic Stress Disorder (PTSD)
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
- Luteal Phase Administration of Paroxetine for the Treatment of PMDD
- Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
- Dementia Antipsychotics And Antidepressants Discontinuation Study
- Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
- Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)
- Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
- Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
- Benefits of Switching Antidepressants Following Early Nonresponse
- Duloxetine for Perimenopausal Depression
- Omacor for Perimenopausal Depression
- A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
- Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
- Duloxetine Versus Paroxetine for Major Depression
- A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway
- AV650 Drug-Drug Interaction Study
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
- The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
- Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
- MDD POC Study GSK372475 Subjects Depressive Disease
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
- A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
- A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
- Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
- A Combination Therapy In Patients With Social Anxiety Disorder
- Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
- Treatment Of Patients With Social Anxiety Disorder
- Antidepressant Safety in Kids Study
- Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
- SSRI Effects on Semen Parameters in Men
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)
- Clinical Pharmacogenomics of Antidepressant Response
- An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
- A Local Register Study For Major Depression Of Paroxetine Controlled Release
- An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
- Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
- Naltrexone & SSRI in Alcoholics With Depression/PTSD
- Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
- Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
- Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
- Nicotinic Receptor Augmentation of SSRI Antidepressants
- Social Anxiety Disorder Study Of Paroxetine
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Quetiapine Augmentation for Treatment-resistant PTSD
- Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain
- A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
- Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
- Clinical Pharmacogenomics of Antidepressant Response
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
- Long-term Study Of Paroxetine in Women and Men
- Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
- Combination Of PAXIL Tablet And Benzodiazepines
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- Study of PET Scans and Serotonin in Hot Flashes Treatment
- Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
- Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
- Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
- Study of Paxil Use in Menopausal Women
- Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
- Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
- Geodon (Ziprasidone) for Posttraumatic Stress Disorder
- Risperidone vs. Paroxetine for Panic Attacks
- Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin
- Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
- Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
- Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response
- RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
- Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
- Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
- Paroxetine in the Treatment of Chronic Primary Insomnia
- Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
- Aripiprazole as Augmentation for TRD
- Phenytoin as an Augmentation for SSRI Failures
- Comparing Paroxetine and Duloxetine on Cardiovascular Measures
- Study Of Generalized Anxiety Disorder
- Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
- Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
- Seroquel in Bipolar Depression Versus SSRI
- Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
- Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
- Chronic Low Back Pain Research Project
- Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance
- Serotonin and the Upper Airway in Obstructive Sleep Apnea
- Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
- Study of Antidepressants in Parkinson's Disease
- Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
- Depression Study In Elderly Patients
- Treatment of Depression in Parkinson's Disease Trial
- Major Depressive Disorder Study In Adults
- A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
- Brain Receptor Function in Post-Traumatic Stress Disorder
- Study Evaluating Venlafaxine ER in Patients With Panic Disorder
- St. John's Wort Versus Placebo in Social Phobia
- Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
- Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
- Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
- Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
- Biological Aspects of Depression and Antidepressant Drugs
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
- Treatment of Panic Disorder: Long Term Strategies
Clinical trials list
click for details